메뉴 건너뛰기




Volumn 11, Issue 3, 2011, Pages 289-292

Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: A case report and review of the literature

Author keywords

Crohn's disease; Hodgkin lymphoma; Immunosuppression; Lymphoproliferative disorder; Reed Sternberg cells; TNF inhibitor

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CONTRAST MEDIUM; PREDNISONE; STEROID; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

EID: 80053355997     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.03.018     Document Type: Article
Times cited : (19)

References (23)
  • 1
    • 33644855102 scopus 로고    scopus 로고
    • American gastroenterological association institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
    • DOI 10.1053/j.gastro.2006.01.047, PII S0016508506000734
    • G.R. Lichtenstein, M.T. Abreu, and R. Cohen American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease Gastroenterology 130 2006 935 939 (Pubitemid 43374542)
    • (2006) Gastroenterology , vol.130 , Issue.3 , pp. 935-939
    • Lichtenstein, G.R.1    Abreu, M.T.2    Cohen, R.3    Tremaine, W.4
  • 2
    • 35649016260 scopus 로고    scopus 로고
    • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
    • D.E. Furst, E.C. Keystone, and B. Kirkham Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008 Ann Rheum Dis 67 suppl 3 2008 iii2 iii25
    • (2008) Ann Rheum Dis , vol.67 , Issue.SUPPL. 3
    • Furst, D.E.1    Keystone, E.C.2    Kirkham, B.3
  • 3
    • 70149109879 scopus 로고    scopus 로고
    • Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: A randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
    • A.M. Alousi, D.J. Weisdorf, and B.R. Logan Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network Blood 114 2009 511 517
    • (2009) Blood , vol.114 , pp. 511-517
    • Alousi, A.M.1    Weisdorf, D.J.2    Logan, B.R.3
  • 4
    • 62549084077 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma
    • S.E. Wenzel, P.J. Barnes, and E.R. Bleecker A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma Am J Respir Crit Care Med 179 2009 549 558
    • (2009) Am J Respir Crit Care Med , vol.179 , pp. 549-558
    • Wenzel, S.E.1    Barnes, P.J.2    Bleecker, E.R.3
  • 5
    • 33646696885 scopus 로고    scopus 로고
    • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    • DOI 10.1001/jama.295.19.2275
    • T. Bongartz, A.J. Sutton, and M.J. Sweeting Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2006 2275 2285 (Pubitemid 43736578)
    • (2006) Journal of the American Medical Association , vol.295 , Issue.19 , pp. 2275-2285
    • Bongartz, T.1    Sutton, A.J.2    Sweeting, M.J.3    Buchan, I.4    Matteson, E.L.5    Montori, V.6
  • 6
    • 0028988635 scopus 로고
    • Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report
    • N.L. Bartlett, S.A. Rosenberg, and R.T. Hoppe Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report J Clin Oncol 13 1995 1080 1088
    • (1995) J Clin Oncol , vol.13 , pp. 1080-1088
    • Bartlett, N.L.1    Rosenberg, S.A.2    Hoppe, R.T.3
  • 8
    • 0036900501 scopus 로고    scopus 로고
    • Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration
    • DOI 10.1002/art.10679
    • S.L. Brown, M.H. Greene, and S.K. Gershon Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration Arthritis Rheum 46 2002 3151 3158 (Pubitemid 35453523)
    • (2002) Arthritis and Rheumatism , vol.46 , Issue.12 , pp. 3151-3158
    • Brown, S.L.1    Greene, M.H.2    Gershon, S.K.3    Edwards, E.T.4    Braun, M.M.5
  • 11
    • 0032738644 scopus 로고    scopus 로고
    • The relationship between infliximab treatment and lymphoma in Crohn's disease
    • S.J. Bickston, G.R. Lichtenstein, and K.O. Arseneau The relationship between infliximab treatment and lymphoma in Crohn's disease Gastroenterology 117 1999 1433 1437
    • (1999) Gastroenterology , vol.117 , pp. 1433-1437
    • Bickston, S.J.1    Lichtenstein, G.R.2    Arseneau, K.O.3
  • 12
    • 49049094614 scopus 로고    scopus 로고
    • Hodgkin's lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: Supplemental case report
    • L. Imundo Hodgkin's lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: supplemental case report J Rheumatol 35 2008 1681
    • (2008) J Rheumatol , vol.35 , pp. 1681
    • Imundo, L.1
  • 13
    • 77950394280 scopus 로고    scopus 로고
    • How i treat EBV lymphoproliferation
    • H.E. Heslop How I treat EBV lymphoproliferation Blood 114 2009 4002 4008
    • (2009) Blood , vol.114 , pp. 4002-4008
    • Heslop, H.E.1
  • 15
    • 0033610627 scopus 로고    scopus 로고
    • Epstein-Barr virus-induced posttransplant lymphoproliferative disorders ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting
    • C.V. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virus-induced posttransplant lymphoproliferative disorders ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting Transplantation 68 1999 1517 1525
    • (1999) Transplantation , vol.68 , pp. 1517-1525
    • Paya, C.V.1    Fung, J.J.2    Nalesnik, M.A.3
  • 16
    • 49249097559 scopus 로고    scopus 로고
    • Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder
    • L.J. Swinnen, M. LeBlanc, and T.M. Grogan Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder Transplantation 86 2008 215 222
    • (2008) Transplantation , vol.86 , pp. 215-222
    • Swinnen, L.J.1    Leblanc, M.2    Grogan, T.M.3
  • 17
    • 0033781798 scopus 로고    scopus 로고
    • Hodgkin's disease and the Epstein-Barr virus
    • K.J. Flavell, and P.G. Murray Hodgkin's disease and the Epstein-Barr virus Mol Pathol 53 2000 262 269
    • (2000) Mol Pathol , vol.53 , pp. 262-269
    • Flavell, K.J.1    Murray, P.G.2
  • 18
    • 54249168688 scopus 로고    scopus 로고
    • AIDS-related malignancies: State of the art and therapeutic challenges
    • J.P. Spano, D. Costagliola, and C. Katlama AIDS-related malignancies: state of the art and therapeutic challenges J Clin Oncol 26 2008 4834 4842
    • (2008) J Clin Oncol , vol.26 , pp. 4834-4842
    • Spano, J.P.1    Costagliola, D.2    Katlama, C.3
  • 19
    • 0025908226 scopus 로고
    • AIDS-associated non-Hodgkin lymphoma
    • V. Beral, T. Peterman, and R. Berkelman AIDS-associated non-Hodgkin lymphoma Lancet 337 1991 805 809
    • (1991) Lancet , vol.337 , pp. 805-809
    • Beral, V.1    Peterman, T.2    Berkelman, R.3
  • 20
    • 0035760292 scopus 로고    scopus 로고
    • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
    • O. Kirk, C. Pedersen, and A. Cozzi-Lepri Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy Blood 98 2001 3406 3412
    • (2001) Blood , vol.98 , pp. 3406-3412
    • Kirk, O.1    Pedersen, C.2    Cozzi-Lepri, A.3
  • 22
    • 13244273520 scopus 로고    scopus 로고
    • Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)
    • DOI 10.1080/10428190400015733
    • T. Wolf, H.R. Brodt, and S. Fichtlscherer Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART) Leuk Lymphoma 46 2005 207 215 (Pubitemid 40185950)
    • (2005) Leukemia and Lymphoma , vol.46 , Issue.2 , pp. 207-215
    • Wolf, T.1    Brodt, H.-R.2    Fichtlscherer, S.3    Mantzsch, K.4    Hoelzer, D.5    Helm, E.B.6    Mitrou, P.S.7    Chow, K.U.8
  • 23
    • 0035072134 scopus 로고    scopus 로고
    • Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antireroviral therapy (HAART)
    • K.U. Chow, P.S. Mitrou, and K. Geduldig Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART) Leuk Lymphoma 41 2001 105 116 (Pubitemid 32294194)
    • (2001) Leukemia and Lymphoma , vol.41 , Issue.1-2 , pp. 105-116
    • Chow, K.U.1    Mitrou, P.S.2    Geduldig, K.3    Helm, E.B.4    Hoelzer, D.5    Brodt, H.-R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.